Activity & Safety Study of KX2-391 Ointment in Participants With Actinic Keratosis on the Face or Scalp
Public ClinicalTrials.gov record NCT02838628. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2a, Open-Label, Multicenter, Activity and Safety Study of KX2-391 Ointment 1% in Subjects With Actinic Keratosis on the Face or Scalp
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
In this study, the activity, safety, and pharmacokinetics (PK) of KX2-391 Ointment was evaluated in adult participants with a clinical diagnosis of stable, clinically typical actinic keratosis (AK) on the face or scalp.
Study identification
- NCT ID
- NCT02838628
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 168 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 10, 2016
- Primary completion
- Jan 10, 2017
- Completion
- Dec 21, 2017
- Last update posted
- Apr 13, 2021
2016 – 2017
United States locations
- U.S. sites
- 16
- U.S. states
- 7
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Center for Dermatology Clinical Research | Fremont | California | 94538 | — |
| eStudy Site | La Mesa | California | 91942 | — |
| Palmtree Clinical Research, Inc. | Palm Springs | California | 92262 | — |
| Horizons Clinical Research Center | Denver | Colorado | 80220 | — |
| Clinical Research of South Florida | Coral Gables | Florida | 33134 | — |
| International Dermatology Research | Miami | Florida | 33144 | — |
| Compass Research | Orlando | Florida | 32806 | — |
| Forward Clinical Trials, Inc. | Tampa | Florida | 33624 | — |
| Palm Beach Research Center | West Palm Beach | Florida | 33409 | — |
| Minnesota Clinical Study Center | Fridley | Minnesota | 55432 | — |
| Dermatology and Laser Center of Charleston | Charleston | South Carolina | 29414 | — |
| Institute of Clinical Research - Tennessee, LLC | Murfreesboro | Tennessee | 37130 | — |
| J&S Studies, Inc. | College Station | Texas | 77845 | — |
| The Center for Skin Research | Houston | Texas | 77056 | — |
| Clinical Trials of Texas, Inc. | San Antonio | Texas | 78229 | — |
| Dermatology Clinical Research Center | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02838628, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 13, 2021 · Synced Sep 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02838628 live on ClinicalTrials.gov.